David A. Metcalfe - 22 Sep 2022 Form 4 Insider Report for NEXTGEN HEALTHCARE, INC.

Role
Chief Technology Officer
Signature
/s/ Jeffrey D. Linton, Attorney-in-Fact for David A. Metcalfe
Issuer symbol
N/A
Transactions as of
22 Sep 2022
Net transactions value
-$44,950
Form type
4
Filing time
26 Sep 2022, 17:36:54 UTC
Previous filing
12 Aug 2022
Next filing
25 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NXGN Common Stock Options Exercise +5,328 +3.5% 155,507 22 Sep 2022 Direct F1
transaction NXGN Common Stock Tax liability $44,950 -2,641 -1.7% $17.02 152,866 22 Sep 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXGN Performance Stock Units Options Exercise $0 -5,328 -3.1% $0.000000 164,213 22 Sep 2022 Common Stock 5,328 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance stock units convert to shares of NXGN common stock on a one-for-one basis once fully vested.
F2 Represents shares withheld to satisfy tax withholding obligations on the vesting of performance stock units.
F3 The reporting person was granted performance stock units that vest upon both the attainment of four separate pre-determined stock price milestones and continued service over a period of three years commencing September 22, 2021. 15,984 of these performance stock units were tied to a stock price milestone of $19.38, which was met in April 2022. As of September 22, 2022, 1/3 of the performance stock units tied to the $19.38 stock price milestone are fully vested. The remaining 10,656 performance stock units tied to the $19.38 stock price milestone will vest in equal installments on September 22, 2023 and September 22, 2024.